Please Subscribe to get a daily link to Pat's blog via email


Your privacy is important to us. We will never spam you and keep your personal data secure.


7 02, 2012

Looks like I just might be around for awhile…

Tags: , , , , , , |29 Comments

I met with my myeloma specialist, Dr. Melissa Alsina, at Moffitt Cancer Center in Tampa yesterday. Great news!  After completing my third, six week full dose RVD chemotherapy cycle, I learned that my monclonal protein reading (M-spike) has continued to edge downward. Let me back-up and fill-in a few of the blanks for our new

22 09, 2011

Thoughts About Timing A Stem Cell Transplant

Tags: , , , , |0 Comments

For those of you who didn't see this, I wanted to share these excerpts from a Cure Magazine/Reuters article about timing a stem cell transplant: With new induction drugs for multiple myeloma, still OK to delay stem cell transplant SEPTEMBER 16, 2011 NEW YORK (Reuters Health) - In patients with multiple myeloma treated initially with

15 04, 2011

A Quick Shout-Out To Roni At The Florida Cancer Institute!

Tags: , , , , , , |2 Comments

I just completed my second week of my first RVD (Revlimid/Velcade/dex) induction cycle.  I get my Velcade/dex IV at a local cancer center 10 minutes from my home.  Very convenient.  This place is always busy.  There must be forty infusion chairs, tightly packed together.  But I couldn't be more pleased if I were in a

22 12, 2010

What Our Doctors Read Influences How Patients Are Treated – For Now That Means Using Lots Of Drugs & Invasive, Expensive Transplants

Tags: , , , , , , , , , |8 Comments

What our doctors read in medical journals and publications which summarize research results and new therapy trends greatly influences how they are likely to act.Case in point:  Here is an article from the trade publication, Internal Medicine News about what is soon to be considered the "standard of care" for multiple myeloma patients:ORLANDO – For patients

20 12, 2010

More Ways To Raise Your Multiple Myeloma IQ

Tags: , , , , , , , |2 Comments

Saturday I started sharing some basics for newly diagnosed multiple myeloma patients and caregivers, Tips To Raise Your Multiple Myeloma IQ.We covered the what, how's and why's about interpreting a prognosis, how genetic abnormalities can complicate a diagnosis and understanding median life expectancy.  I can't emphasize enough how important it is to get a second opinion

22 10, 2010

An Inside Look At How Top Myeloma Experts Feel About Induction Therapy & Use Of SCT In Newly Diagnosed Multiple Myeloma Patients

Tags: , , , , , , |0 Comments

HemOnctoday posted an excellent review of the new, state of the art anti-myeloma induction therapy using a combination of Revlimid, Velcade and dexamethasone (RVD) last week.  The article features a number of well known myeloma experts and is quite long. Toward the end of the article, yesterday's topic about whether to continue using stem cell transplant

13 08, 2010

Velcade Plus Dex Improves Survival Of Multiple Myeloma Patients With 4/14 Chromosome Deletion When Used During Induction

Tags: , , , , |1 Comment reports there is some good news for multiple myeloma patients with chromosomal abnormalities:Bortezomib Plus Dexamethasone Induction Improves Outcome of Patients With t(4;14) Myeloma but Not Outcome of Patients With del(17p)TAKE-HOME MESSAGEIn this large, retrospective analysis of patients with newly diagnosed multiple myeloma, bortezomib-based induction therapy before high-dose melphalan and stem cell transplantation was associated